Multicentric outcome analysis of sirolimus-based immunosuppression in 252 liver transplant recipients.
about
Conversion of calcineurin inhibitor treatment to target of rapamycin inhibitor treatment versus continuation of calcineurin inhibitor treatment for liver transplant recipientsOutcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantationThe benefit of sirolimus maintenance immunosuppression and rabbit antithymocyte globulin induction in liver transplant recipients that develop acute kidney injury in the early postoperative periodReview on immunosuppression in liver transplantation.Should diabetic women with breast cancer have their own intervention studies?Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients.The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence.Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients.Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients.A Decade of Experience Using mTor Inhibitors in Liver Transplantation.Taking the rap: multiple effects of blocking mammalian target of rapamycin.Prophylaxis with enoxaparin for prevention of venous thromboembolism after lung transplantation: a retrospective study.De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.
P2860
Q24234041-562B7FE3-21A1-451E-B87E-B9509D26D365Q26864478-01A96DD0-63C2-4D39-8086-8C2BABF683EBQ30300206-85BB8D7C-34B1-4B93-8850-747BD5DB5915Q35668757-76BE99EE-72C6-4A5A-972B-6D56FFD6049DQ36923125-4A18DFCC-6C09-4274-BA9B-0F013C2B4F48Q37355472-B63D1F7E-FF18-4582-8105-2267F5A12D23Q37639714-FE070E1E-B591-4B47-B11D-C1E720E9D3EFQ37946501-A7BAC010-91B4-4212-A667-11492538BC38Q41888593-D5E7AD9D-7C08-4C5E-9922-A2C613009686Q42704361-5DA0D6DD-AB83-4353-A9E9-9160BAF46BA9Q45109894-5B456189-FBA6-4BE0-94CD-7FFCAD50CF6BQ48249771-C64208C0-A4DE-40FD-88BA-A45FACFA1C64Q53096322-32472D1E-4E7C-4C19-86C7-67AEFAAFE0BD
P2860
Multicentric outcome analysis of sirolimus-based immunosuppression in 252 liver transplant recipients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Multicentric outcome analysis ...... 2 liver transplant recipients.
@en
Multicentric outcome analysis ...... 2 liver transplant recipients.
@nl
type
label
Multicentric outcome analysis ...... 2 liver transplant recipients.
@en
Multicentric outcome analysis ...... 2 liver transplant recipients.
@nl
prefLabel
Multicentric outcome analysis ...... 2 liver transplant recipients.
@en
Multicentric outcome analysis ...... 2 liver transplant recipients.
@nl
P2093
P2860
P1476
Multicentric outcome analysis ...... 2 liver transplant recipients.
@en
P2093
David Bigam
Glenda Meeberg
James A Shapiro
James F Trotter
Kenneth Berman
Michele Molinari
Norman Kneteman
P2860
P304
P356
10.1111/J.1432-2277.2009.00969.X
P577
2009-09-18T00:00:00Z